Measles passive immunity in infants from vaccinated and disease acquired mothers
Author
dc.contributor.author
Silva, Juan J.
Author
dc.contributor.author
Fernández, Maria Del Pilar
Author
dc.contributor.author
Suárez, Mónica
Author
dc.contributor.author
Toledo, Maria
Author
dc.contributor.author
Silva, Cecilia A.
Admission date
dc.date.accessioned
2019-01-29T15:50:04Z
Available date
dc.date.available
2019-01-29T15:50:04Z
Publication date
dc.date.issued
1994
Cita de ítem
dc.identifier.citation
Pharmacoepidemiology and Drug Safety, Volumen 3, Issue 4, 2018, Pages 199-203
Identifier
dc.identifier.issn
10991557
Identifier
dc.identifier.issn
10538569
Identifier
dc.identifier.other
10.1002/pds.2630030404
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/162545
Abstract
dc.description.abstract
Background — Despite the decline in the incidence of measles in Chile, epidemics continue to occur. In Chile, measles vaccine is administered at one year of age, therefore, we hypothesized that control of epidemic measles may be improved with a better understanding of the immunologic status of infants. Objective — To evaluate the immunologic status to measles of unvaccinated infants born to previously vaccinated and disease exposed mothers. Method — Group A subjects were pregnant women with a documented history of measles infection, and group B subjects were pregnant women with a documented history of measles vaccination. Maternal blood samples and cord blood were obtained immediately following delivery. Blood samples were obtained from infants at 6 and 9 months of age. Samples were tested for anti‐measles antibodies using an ELISA technique. Results — There were 41 subjects in group A and 35 in group B. Infant birth weight and the mothers age were comparable in the two groups. At deli